Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Robot-Assisted vs Manual Transradial Cerebral Angiography

NCT07696936 · The First Hospital of Hebei Medical University · Updated 10 July 2026

What is being tested
Robot-assisted angiographic system; Manual controlled transradial artery angiography
For
Angiography, Digital Subtraction; Robot-assisted Therapy
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 156 people. The full rules are on the registry page.
Where
China
When
Starts or started 30 Nov 2025, ends 30 Sept 2029. Registered 10 July 2026.
Results
None posted yet.

In the researchers' words

This is a prospective, randomized controlled clinical trial designed to compare the safety and effectiveness of robot-assisted transradial cerebral angiography versus manual operation performed by experienced neurosurgeons. The study will be conducted at the Department of Neurosurgery, The First Hospital of Hebei Medical University, with a total sample size of 156 participants. Why is this study being done? Cerebral angiography is a key diagnostic procedure for cerebrovascular diseases, such as stroke, aneurysm, and vascular malformation. Traditionally, it is performed manually by interventional physicians, who are exposed to significant radiation during the procedure. Robot-assisted technology offers a potential solution by allowing doctors to operate from a separate, shielded room, which could greatly reduce occupational radiation exposure. This study aims to verify whether robot-assisted transradial cerebral angiography is non-inferior to the standard manual approach in terms of safety and clinical success, while providing additional benefits for both patients and physicians. Who can participate? We plan to enroll 156 adult patients (aged 18-80 years) who meet the following criteria: Stable vital signs and eligible for routine cerebral angiography Suspected intracranial vascular lesions or need for evaluation of intracranial mass blood supply, confirmed by CTA/MRA…
ClinicalTrials.gov, NCT07696936

Sites

  • The First Hospital of Hebei Medical UniversityShijiazhuang, Hebei, China